1. Home
  2. THTX vs HEQ Comparison

THTX vs HEQ Comparison

Compare THTX & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • HEQ
  • Stock Information
  • Founded
  • THTX 1993
  • HEQ 2011
  • Country
  • THTX Canada
  • HEQ United States
  • Employees
  • THTX N/A
  • HEQ N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • HEQ Investment Managers
  • Sector
  • THTX Health Care
  • HEQ Finance
  • Exchange
  • THTX Nasdaq
  • HEQ Nasdaq
  • Market Cap
  • THTX 119.1M
  • HEQ 127.0M
  • IPO Year
  • THTX N/A
  • HEQ N/A
  • Fundamental
  • Price
  • THTX $3.15
  • HEQ $10.59
  • Analyst Decision
  • THTX Hold
  • HEQ
  • Analyst Count
  • THTX 1
  • HEQ 0
  • Target Price
  • THTX N/A
  • HEQ N/A
  • AVG Volume (30 Days)
  • THTX 1.0M
  • HEQ 43.1K
  • Earning Date
  • THTX 07-09-2025
  • HEQ 01-01-0001
  • Dividend Yield
  • THTX N/A
  • HEQ 9.78%
  • EPS Growth
  • THTX N/A
  • HEQ N/A
  • EPS
  • THTX N/A
  • HEQ N/A
  • Revenue
  • THTX $84,378,000.00
  • HEQ N/A
  • Revenue This Year
  • THTX N/A
  • HEQ N/A
  • Revenue Next Year
  • THTX $15.13
  • HEQ N/A
  • P/E Ratio
  • THTX N/A
  • HEQ N/A
  • Revenue Growth
  • THTX 2.19
  • HEQ N/A
  • 52 Week Low
  • THTX $1.12
  • HEQ $9.08
  • 52 Week High
  • THTX $3.20
  • HEQ $11.84
  • Technical
  • Relative Strength Index (RSI)
  • THTX 73.34
  • HEQ 53.61
  • Support Level
  • THTX $2.28
  • HEQ $10.45
  • Resistance Level
  • THTX $3.20
  • HEQ $10.73
  • Average True Range (ATR)
  • THTX 0.09
  • HEQ 0.08
  • MACD
  • THTX 0.09
  • HEQ 0.00
  • Stochastic Oscillator
  • THTX 94.86
  • HEQ 61.11

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: